- Molnlycke donates risk prediction patent to SKF’s digital patent platform
- Study finds at-home brain stimulation therapies reduce depression relapse rate
- Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
- EVerZom enters research and licensing agreement with GENFIT
- University of Birmingham scientists develop new MRI contrast agent
- Custom Pharmaceuticals launches new company for drug product development
- Novartis receives SMC approval for early breast cancer treatment
- Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers
- Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
- Vesper Bio reports positive topline results for dementia candidate
- AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders
- Ardena appoints new Chief Quality Officer and Chief Information Officer
- Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO
- Von Willebrand disease – increasing awareness and access to vital care
- Rethinking oncology trial endpoints with generalised pairwise comparisons